{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:13:17Z","timestamp":1788415997364,"version":"build-2803163510"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Syst. Biol."],"abstract":"<jats:p>\n                    Arenavirus-based vectors are uniquely positioned to generate durable T cell responses against tumors, which remains a central challenge in cancer immunotherapy. Two members of the arenavirus family, Lymphocytic choriomeningitis virus and Pichinde virus, were genetically engineered to encode a non-oncogenic fusion protein, originating from human papillomavirus 16 E\n                    <jats:sup>6<\/jats:sup>\n                    and E7. Hereafter, these vectors are referred to as HB-201 and HB-202, respectively. HB-201 alone or in combination with HB-202 elicited strong and durable E6\/E7-specific CD8+ T cell responses in HPV 16+ cancer patients. Despite their classification within the same virus family, Lymphocytic choriomeningitis virus and Pichinde virus are phylogenetically distant, which may influence virus-host interactions and the pathways leading to antiviral immune responses. Previous studies showed that both vectors infect and activate professional antigen presenting cells. To elaborate on these findings, this study aimed to characterize in depth the innate immune response to HB-201 and HB-202 by single cell sequencing in an in vitro human PBMCs infection model. We confirmed the preferential infection of antigen presenting cells for both vectors, with HB-201 infecting the cross-priming conventional dendritic cell subset cDC1 more efficiently than HB-202. Furthermore, HB-201 induced stronger type I interferon responses than HB-202, as well as quantitative and qualitative differences in inflammatory response associated with a distinct reshaping of monocyte subsets towards intermediate and non-classical monocytes. Antigen presentation and T cell priming cytokines in dendritic cells appeared to favor antiviral CD8+ T cell responses upon HB-201 infection, whereas a more balanced CD4+ and CD8+ priming profile was observed upon HB-202 infection. Immunogenicity data from patients treated with HB-201 and HB-202 confirmed the in vitro findings with functional differences in early T cell response. Thus, despite their shared origins within the arenavirus family, HB- 201 and HB-202 demonstrate distinct differences in early host-virus interaction, potentially resulting in shaping unique T cell responses.\n                  <\/jats:p>","DOI":"10.3389\/fsysb.2026.1897043","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:37Z","timestamp":1788412897000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Innate immune activation profiles are associated with polarization of the T cell response to recombinant arenaviral vectors"],"prefix":"10.3389","volume":"6","author":[{"given":"Sarah","family":"Szaffich","sequence":"first","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]},{"name":"Medical University of Vienna","place":["Vienna, Vienna, Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Just","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Cvetkovic","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Pepic","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwendinger","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia","family":"Katchar","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus K.","family":"Orlinger","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Lauterbach","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josipa","family":"Raguz","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katell","family":"Bidet Huang","sequence":"additional","affiliation":[{"name":"Hookipa Pharma Inc.","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/cells11121979","article-title":"The good and the bad: monocytes\u2019 and macrophages\u2019 diverse functions in inflammation","volume":"11","author":"Austermann","year":"2022","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1016\/j.xcrm.2021.100209","article-title":"Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack","volume":"2","author":"Bonilla","year":"2021","journal-title":"Cell Rep. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0176460","DOI":"10.1371\/journal.pone.0176460","article-title":"Phenotype, function, and differentiation potential of human monocyte subsets","volume":"12","author":"Boyette","year":"2017","journal-title":"PLoS ONE"},{"key":"B4","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1128\/IAI.9.5.821-823.1974","article-title":"Serological evidence of infection by pichinde virus among laboratory workers","volume":"9","author":"Buchmeier","year":"1974","journal-title":"Infect. Immun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.immuni.2024.03.014","article-title":"Control of adaptive immunity by pattern recognition receptors","volume":"57","author":"Carroll","year":"2024","journal-title":"Immunity"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a package for the generation of highly-customizable venn and euler diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinforma."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1158\/1538-7445.am2022-3284","article-title":"Abstract 3284: HB-201 and HB-202, an arenavirus-based immunotherapy, induces tumor T cell infiltration in patients with HNSCC and other HPV16+ tumors","volume":"82","author":"Edwards","year":"2022","journal-title":"Cancer Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"iMeta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e011519","DOI":"10.1136\/jitc-2025-011519","article-title":"Role of cDC2 in priming CD8+ T cells in cancer","volume":"13","author":"Hamouda","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2300343120","DOI":"10.1073\/pnas.2300343120","article-title":"XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors","volume":"120","author":"Heger","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"crossref","first-page":"A770","DOI":"10.1136\/jitc-2023-SITC2023.0679","article-title":"679 characterization of tumor specific CD8+ T cell responses in patients with recurrent\/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study","volume-title":"Regular and Young Investigator Award Abstracts","author":"Ho","year":"2023"},{"key":"B16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1128\/JVI.00009-15","article-title":"In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions","volume":"89","author":"Huang","year":"2015","journal-title":"J. Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/v16040635","article-title":"Pathogenic and apathogenic strains of lymphocytic choriomeningitis virus have distinct entry and innate immune activation pathways","volume":"16","author":"Johnson","year":"2024","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15327","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"LB049","DOI":"10.1158\/1538-7445.am2021-lb049","article-title":"Abstract LB049: preliminary analysis of immunogenicity of HB-201 and HB-202, an arenavirus-based cancer immunotherapy, in patients with advanced HPV16-positive cancers","volume":"81","author":"Katchar","year":"2021","journal-title":"Cancer Res."},{"key":"B21","volume-title":"Pheatmap: Pretty Heatmaps. the R Foundation","author":"Kolde","year":"2024"},{"key":"B22","doi-asserted-by":"publisher","first-page":"732166","DOI":"10.3389\/fonc.2021.732166","article-title":"Development and characterization of a novel non-lytic cancer immunotherapy using a recombinant arenavirus vector platform","volume":"11","author":"Lauterbach","year":"2021","journal-title":"Front. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","article-title":"Activation and evasion of type I interferon responses by SARS-CoV-2","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-3-540-71329-6_14","article-title":"Viral regulation and evasion of the host response","volume":"316","author":"Loo","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1236923","DOI":"10.3389\/fimmu.2023.1236923","article-title":"IRF7: role and regulation in immunity and autoimmunity","volume":"14","author":"Ma","year":"2023","journal-title":"Front. Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.057000-0","article-title":"Comparative analysis of disease pathogenesis and molecular mechanisms of new world and old world arenavirus infections","volume":"95","author":"McLay","year":"2014","journal-title":"J. Gen. Virol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1128\/JVI.68.3.1951-1955.1994","article-title":"Resistance of lymphocytic choriomeningitis virus to alpha\/beta interferon and to gamma interferon","volume":"68","author":"Moskophidis","year":"1994","journal-title":"J. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.1128\/jvi.75.18.8407-8423.2001","article-title":"Critical role for alpha\/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells","volume":"75","author":"Ou","year":"2001","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12985-025-02803-w","article-title":"Serotype-specific host proteome remodeling in human foreskin fibroblasts during lytic HSV-1 and HSV-2 infection","volume":"22","author":"Pan","year":"2025","journal-title":"Virol. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/imr.12001","article-title":"Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation","volume":"250","author":"Piehler","year":"2012","journal-title":"Immunol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1128\/JVI.00187-12","article-title":"Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKK\u03b5","volume":"86","author":"Pythoud","year":"2012","journal-title":"J. Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e008286","DOI":"10.1136\/jitc-2023-008286","article-title":"Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment","volume":"12","author":"Raguz","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1038\/s41598-020-65939-5","article-title":"Analysis of cell-associated DENV RNA by oligo(dT) primed 5\u2019 capture scRNAseq","volume":"10","author":"Sanborn","year":"2020","journal-title":"Sci. Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/s41423-019-0220-6","article-title":"Helper T cell differentiation","volume":"16","author":"Saravia","year":"2019","journal-title":"Cell Mol. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1809960","DOI":"10.1080\/2162402x.2020.1809960","article-title":"Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer","volume":"9","author":"Schmidt","year":"2020","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1009800","DOI":"10.1371\/journal.ppat.1009800","article-title":"SARS-CoV-2 suppresses IFN\u03b2 production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon","volume":"17","author":"Shemesh","year":"2021","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"B38","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e70069","DOI":"10.1111\/imr.70069","article-title":"Functional specialization and collaboration of cDC2 subsets in CD4+ T cell priming and differentiation","volume":"336","author":"Tatsumi","year":"2025","journal-title":"Immunol. Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.12688\/f1000research.9997.1","article-title":"The role of cDC1s in vivo: CD8 T cell priming through cross-presentation. [version 1; peer review: 3 approved]","volume":"6","author":"Theisen","year":"2017","journal-title":"F1000Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"key":"B42","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1128\/JVI.01682-12","article-title":"Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly","volume":"86","author":"Verhelst","year":"2012","journal-title":"J. Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e714","DOI":"10.1002\/mco2.714","article-title":"The interaction of innate immune and adaptive immune system","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1249731","DOI":"10.3389\/fimmu.2023.1249731","article-title":"Multi-omics analysis reveals interferon-stimulated gene OAS1 as a prognostic and immunological biomarker in pan-cancer","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1128\/JVI.00702-12","article-title":"Comparison of the host immune response to Herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites","volume":"86","author":"Zheng","year":"2012","journal-title":"J. Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"giy083","DOI":"10.1093\/gigascience\/giy083","article-title":"Clustering trees: a visualization for evaluating clusterings at multiple resolutions","volume":"7","author":"Zappia","year":"2018","journal-title":"Gigascience"},{"key":"B47","doi-asserted-by":"publisher","first-page":"jcs260682","DOI":"10.1242\/jcs.260682","article-title":"Viral evasion of the interferon response at a glance","volume":"136","author":"Zhu","year":"2023","journal-title":"J. Cell Sci."}],"container-title":["Frontiers in Systems Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2026.1897043\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:21:38Z","timestamp":1788412898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsysb.2026.1897043\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":47,"alternative-id":["10.3389\/fsysb.2026.1897043"],"URL":"https:\/\/doi.org\/10.3389\/fsysb.2026.1897043","relation":{},"ISSN":["2674-0702"],"issn-type":[{"value":"2674-0702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1897043"}}